★ Sign in to follow
CW

Carl W. Langren

Executive
US·SEC (Form 4)
Lumos Pharma, Inc.
Total declarations
32
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€1.2M

Latest filing published 05 Apr 2021 for Lumos Pharma, INC., €7,103.

Filing timeline

BuySale
Carl W. Langren

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

Carl W. Langren: trading record in brief

All filings by Carl W. Langren on record concern Lumos Pharma, Inc. In total, 32 filings cover trades dated from 2 January 2014 to 1 April 2021.

The open-market record consists of 12 sales worth €1.2M, with no purchase. Outside the open market, there are 14 share grants and 2 option exercises.

The newest entry dates from 5 April 2021: a share grant of €7,103, in Lumos Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Carl W. Langren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    8,367 USD20SEC
    683 shares@ US$12.255.1% of flowCommon StockSEC:0001126234-21-000043:0
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    0SEC
    939 shares0Common StockSEC:0001126234-21-000009:0
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    0SEC
    9,000 shares0Common StockSEC:0001126234-20-000046:0
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    621 USD19SEC
    281 shares@ US$2.211.4% of flowCommon StockSEC:0001126234-20-000005:0
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    1,072 USD19SEC
    646 shares@ US$1.662.0% of flowCommon StockSEC:0001126234-19-000011:0
  • ◆
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    617 USD19SEC
    398 shares@ US$1.551.1% of flowCommon StockSEC:0001126234-19-000011:1
  • ◇
    Carl W. Langren
    Chief Financial OfficerExecutivesLumos Pharma, Inc.
    2,051 USD19SEC
    2,564 shares@ US$0.803.8% of flowCommon StockSEC:0001126234-18-000152:0
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    7,479 USD19SEC
    883 shares@ US$8.474.7% of flowCommon StockSEC:0001126234-18-000011:0
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    2,585 USD19SEC
    257 shares@ US$10.061.6% of flowCommon StockSEC:0001126234-18-000011:1
  • ◇
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    19,998 USD20SEC
    9,523 shares@ US$2.1012.8% of flowCommon StockSEC:0001126234-17-000115:0
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    20,172 USD20SEC
    2,229 shares@ US$9.0512.9% of flowCommon StockSEC:0001126234-17-000115:1
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    9,077 USD20SEC
    883 shares@ US$10.286.5% of flowCommon StockSEC:0001126234-17-000009:0
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    2,837 USD19SEC
    257 shares@ US$11.042.0% of flowCommon StockSEC:0001126234-17-000009:1
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    42,782 USD22SEC
    3,943 shares@ US$10.8530.2% of flowCommon StockSEC:0001126234-16-000329:0
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    0SEC
    3,142 sharesCommon StockSEC:0001126234-16-000210:0
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    20,587 USD42SEC
    595 shares@ US$34.6053.8% of flowCommon StockSEC:0001126234-16-000210:1
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    17,710 USD42SEC
    500 shares@ US$35.4246.2% of flowCommon StockSEC:0001126234-16-000210:2
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    132,500 USD0SEC
    2,500 shares@ US$53.00Common StockSEC:0001126234-15-000062:0
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    181,737 USD0SEC
    3,429 shares@ US$53.00Common StockSEC:0001126234-15-000062:1
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    371,000 USD0SEC
    7,000 shares@ US$53.00Common StockSEC:0001126234-15-000062:3
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    24,051 USD0SEC
    551 shares@ US$43.65Common StockSEC:0001126234-15-000004:0
  • ◆
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    0SEC
    5,100 shares0Common StockSEC:0001126234-15-000004:1
  • ●
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    1M USD0SEC
    56,691 shares@ US$18.96Common StockSEC:0001126234-14-000167:0
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    124,863 USD0SEC
    3,587 shares@ US$34.81Common StockSEC:0001126234-14-000052:0
  • ▼
    Carl W. Langren
    Principal Accounting OfficerExecutivesLumos Pharma, Inc.
    124,829 USD0SEC
    3,586 shares@ US$34.81Common StockSEC:0001126234-14-000052:1

25 of 30 declarations

Related entities

No related entities found.